Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.
Holgate ST; Chuchalin AG; Hébert J; Lötvall J; Persson GB; Chung KF; Bousquet J; Kerstjens HA; Fox H; Thirlwell J; Cioppa GD; Clinical And Experimental Allergy: Journal Of The British Society For Allergy And Clinical Immunology, 2004, vol. 34, issue 4, p 632, ISSN 09547894. ISBN 09547894.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef